US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Definium Therapeutics

38.89

+1.163.07%

Post-market: 39.000.1100+0.28%19:55 EDT

Volume:1.75M

Turnover:68.13M

Market Cap:5.23B

PE:-11.17

High:39.37

Open:37.73

Low:37.73

Close:37.73

52wk High:49.70

52wk Low:8.77

Shares:134.37M

Float Shares:131.11M

Volume Ratio:1.28

T/O Rate:1.34%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.4823

EPS(LYR):-2.0600

ROE:-64.09%

ROA:-20.64%

PB:5.69

PE(LYR):-18.88

Loading ...

Overview Company News Filings

Enveric Biosciences up 3%, U.S.‑Listed Shares of Cybin Rise 4.5%

THOMSON REUTERS

Definium Therapeutics Adds 0.4%, Compass Pathways Rises 5.5%

THOMSON REUTERS

Psychedelic Drug Developers Rise After US FDA Moves to Fast-Track Drugs After Trump Order

THOMSON REUTERS

Oppenheimer Adjusts Definium Therapeutics PT to $40 From $25, Maintains Outperform Rating

MT Newswires Live

Definium Therapeutics price target raised to $40 from $25 at Oppenheimer

Definium Therapeutics : Oppenheimer Raises Target Price to $40 From $25

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Zymeworks (ZYME) and Definium Therapeutics (DFTX)

Piper Sandler Sticks to Its Buy Rating for Definium Therapeutics (DFTX)

U.S. RESEARCH ROUNDUP-CME Group, GE Vernova, Texas Instruments

Definium Therapeutics: Strengthened Investment Case and Multi-Indication Upside Ahead of Key Phase 3 Readouts

Definium plans Phase 3 Haven trial of DT120 ODT in PTSD for 2027 start

Definium Therapeutics publishes Investor and Analyst Day presentation materials

Analysts Conflicted on These Healthcare Names: Definium Therapeutics (DFTX) and Certara (CERT)

Definium Therapeutics Is Maintained at Outperform by Leerink Partners

Definium Therapeutics Inc : Leerink Partners Raises Target Price to $30 From $23

THOMSON REUTERS

Stock Track | Definium Therapeutics Soars 6.34% in Pre-market on Trump Executive Order Boosting Psychedelic Drug Sector

Definium Therapeutics (DFTX) Stock Gains After Hours: Here's What's Driving The Move

Benzinga_recent_news

Stock Track | Definium Therapeutics Soars 5.65% as Trump Executive Order Boosts Psychedelic Drug Sector

Psychedelic Stocks Surge After Trump Supports Using Drugs Like LSD for Mental Health

Definium Therapeutics issues inducement stock options for 70,860 shares to new hires

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/DFTX/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"DFTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":38.89,"timestamp":1789156800000,"preClose":37.73,"halted":0,"volume":1754315,"hourTrading":{"tag":"盘后","latestPrice":39,"preClose":38.89,"latestTime":"19:55 EDT","volume":348208,"amount":13541995.6704,"timestamp":1789170913353,"change":0.11,"changeRate":0.002828,"amplitude":0.016804},"delay":0,"changeRate":0.03074476543864309,"floatShares":131114280,"shares":134366950,"eps":-3.482311,"marketStatus":"Market Closed","change":1.16,"latestTime":"09-11 16:00:00 EDT","open":37.73,"high":39.37,"low":37.73,"amount":68131498.355375,"amplitude":0.043467,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.482311,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":37.73,"preHourTrading":{"tag":"盘前","latestPrice":37.9852,"preClose":37.73,"latestTime":"09:18 EDT","volume":4465,"amount":169832.67781,"timestamp":1789132705128,"change":0.2552,"changeRate":0.006764,"amplitude":0.020448},"postHourTrading":{"tag":"盘后","latestPrice":39,"preClose":38.89,"latestTime":"19:55 EDT","volume":348208,"amount":13541995.6704,"timestamp":1789170913353,"change":0.11,"changeRate":0.002828,"amplitude":0.016804},"volumeRatio":1.2818231822401762,"impliedVol":1.3321,"impliedVolPercentile":0.8963},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","floatShares":131114280,"roa":"-20.64%","roe":"-64.09%","lyrEps":-2.059999,"volumeRatio":1.2818231822401762,"shares":134366950,"dividePrice":0,"high":39.37,"amplitude":0.043467,"preClose":37.73,"low":37.73,"week52Low":8.7732,"pbRate":"5.69","week52High":49.7,"institutionHeld":0,"latestPrice":38.89,"eps":-3.482311,"divideRate":0,"volume":1754315,"delay":0,"ttmEps":-3.482311,"open":37.73,"prevYearClose":13.39,"prevWeekClose":38.09,"prevMonthClose":39.72,"prevQuarterClose":47.04,"fiveDayClose":38,"twentyDayClose":43.9,"sixtyDayClose":24.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DFTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"DFTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-1.44},{"market":"US","date":"2026-05-07","symbol":"DFTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.47,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2026-02-26","symbol":"DFTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DFTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DFTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.6111,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6111,"analysts":18,"updateTime":1787025600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DFTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DFTX","date":"2026-09-11","current":-11.167871,"percent":0.337423,"low":-27.074722,"twenty":-17.27056,"median":-11.195675,"eighty":-9.903787,"high":-8.802064,"avg":-13.932943,"sd":5.402262,"marketCap":5069665023},"quantilePoints":[{"date":"2026-01-16","current":-9.013032,"twenty":-8.970838,"median":-8.907548,"eighty":-8.844258,"marketCap":1515072711},{"date":"2026-01-23","current":-9.944809,"twenty":-9.944809,"median":-9.423248,"eighty":-8.819645,"marketCap":1671702464},{"date":"2026-01-30","current":-10.103035,"twenty":-10.103035,"median":-9.868626,"eighty":-9.013032,"marketCap":1698299969},{"date":"2026-02-06","current":-9.522872,"twenty":-10.196799,"median":-9.918438,"eighty":-9.522872,"marketCap":1600775783},{"date":"2026-02-13","current":-9.511152,"twenty":-10.179218,"median":-9.944809,"eighty":-9.522872,"marketCap":1598805598},{"date":"2026-02-20","current":-10.120616,"twenty":-10.18039,"median":-9.944809,"eighty":-9.520528,"marketCap":1701255248},{"date":"2026-02-27","current":-9.267085,"twenty":-10.187422,"median":-9.96239,"eighty":-9.520528,"marketCap":1703225433},{"date":"2026-03-06","current":-9.519961,"twenty":-10.18039,"median":-9.903787,"eighty":-9.502065,"marketCap":1749702163},{"date":"2026-03-13","current":-9.753213,"twenty":-10.18039,"median":-9.918437,"eighty":-9.518199,"marketCap":1792572359},{"date":"2026-03-20","current":-10.122078,"twenty":-10.169841,"median":-9.903787,"eighty":-9.52229,"marketCap":1860367087},{"date":"2026-03-27","current":-10.273963,"twenty":-10.169841,"median":-9.918437,"eighty":-9.559599,"marketCap":1888282563},{"date":"2026-04-02","current":-11.174427,"twenty":-10.181562,"median":-9.918437,"eighty":-9.550417,"marketCap":2053781457},{"date":"2026-04-10","current":-11.619234,"twenty":-10.247114,"median":-9.944809,"eighty":-9.57529,"marketCap":2135533923},{"date":"2026-04-17","current":-12.18338,"twenty":-10.396104,"median":-9.980506,"eighty":-9.589394,"marketCap":2239219977},{"date":"2026-04-24","current":-12.617338,"twenty":-11.167918,"median":-10.038572,"eighty":-9.618687,"marketCap":2318978480},{"date":"2026-05-01","current":-11.86876,"twenty":-11.389236,"median":-10.10442,"eighty":-9.643639,"marketCap":2181395062},{"date":"2026-05-08","current":-13.767387,"twenty":-11.71579,"median":-10.122078,"eighty":-9.665202,"marketCap":2530349365},{"date":"2026-05-15","current":-9.802755,"twenty":-11.643102,"median":-10.113211,"eighty":-9.689477,"marketCap":2328575817},{"date":"2026-05-22","current":-10.399644,"twenty":-11.570414,"median":-10.105791,"eighty":-9.636028,"marketCap":2470362634},{"date":"2026-05-29","current":-10.780735,"twenty":-11.483622,"median":-10.120616,"eighty":-9.642537,"marketCap":2560888064},{"date":"2026-06-05","current":-11.290386,"twenty":-11.393576,"median":-10.145827,"eighty":-9.660184,"marketCap":2681952193},{"date":"2026-06-12","current":-11.069996,"twenty":-11.344489,"median":-10.179218,"eighty":-9.68473,"marketCap":2629600138},{"date":"2026-06-18","current":-11.216923,"twenty":-11.349156,"median":-10.196799,"eighty":-9.702279,"marketCap":2664501508},{"date":"2026-06-26","current":-20.565124,"twenty":-11.510745,"median":-10.247973,"eighty":-9.723056,"marketCap":4885101210},{"date":"2026-07-02","current":-24.252692,"twenty":-11.77112,"median":-10.299843,"eighty":-9.753213,"marketCap":5761057223},{"date":"2026-07-10","current":-27.074722,"twenty":-12.069466,"median":-10.333633,"eighty":-9.796609,"marketCap":6431410656},{"date":"2026-07-17","current":-24.643864,"twenty":-12.519698,"median":-10.492938,"eighty":-9.802755,"marketCap":5853977501},{"date":"2026-07-24","current":-23.990048,"twenty":-12.931958,"median":-10.537388,"eighty":-9.812883,"marketCap":5698667894},{"date":"2026-07-31","current":-24.861803,"twenty":-14.440728,"median":-10.67054,"eighty":-9.817222,"marketCap":5905747370},{"date":"2026-08-07","current":-17.312135,"twenty":-19.588062,"median":-10.789918,"eighty":-9.824231,"marketCap":6124773739},{"date":"2026-08-14","current":-16.673146,"twenty":-17.887875,"median":-10.831241,"eighty":-9.831914,"marketCap":5898709105},{"date":"2026-08-21","current":-17.242844,"twenty":-17.526933,"median":-11.058518,"eighty":-9.861594,"marketCap":6100259530},{"date":"2026-08-28","current":-16.642763,"twenty":-17.426666,"median":-11.092954,"eighty":-9.887379,"marketCap":5887959749},{"date":"2026-09-04","current":-14.432336,"twenty":-17.33018,"median":-11.139168,"eighty":-9.901443,"marketCap":5105944100},{"date":"2026-09-11","current":-14.329791,"twenty":-17.27056,"median":-11.195675,"eighty":-9.903787,"marketCap":5069665023}],"updateTime":1789225733848},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DFTX\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2629842685","title":"Enveric Biosciences up 3%, U.S.‑Listed Shares of Cybin Rise 4.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629842685","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629842685?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:32","pubTimestamp":1777037539,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nL4N4171CD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","GHRS","ENVB","CMPS","BK4139","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629842681","title":"Definium Therapeutics Adds 0.4%, Compass Pathways Rises 5.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629842681","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629842681?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:32","pubTimestamp":1777037538,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nL4N4171CD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ENVB","GHRS","DFTX","BK4539","BK4139","CMPS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629426838","title":"Psychedelic Drug Developers Rise After US FDA Moves to Fast-Track Drugs After Trump Order","url":"https://stock-news.laohu8.com/highlight/detail?id=2629426838","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629426838?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:32","pubTimestamp":1777037537,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nL4N4171CD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CMPS","GHRS","DFTX","ENVB","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629830008","title":"Oppenheimer Adjusts Definium Therapeutics PT to $40 From $25, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2629830008","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629830008?lang=en_us&edition=fundamental","pubTime":"2026-04-23 22:02","pubTimestamp":1776952941,"startTime":"0","endTime":"0","summary":"Definium Therapeutics, Inc. (DFTX) has an average rating of Buy and mean price target of $38.87, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fr","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPY","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629832855","title":"Definium Therapeutics price target raised to $40 from $25 at Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2629832855","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629832855?lang=en_us&edition=fundamental","pubTime":"2026-04-23 20:59","pubTimestamp":1776949189,"startTime":"0","endTime":"0","summary":"Oppenheimer raised the firm’s price target on Definium Therapeutics (DFTX) to $40 from $25 and keeps an Outperform rating on the shares. The firm a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-40-from-25-at-oppenheimer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-raised-to-40-from-25-at-oppenheimer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPY","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629831820","title":"Definium Therapeutics : Oppenheimer Raises Target Price to $40 From $25","url":"https://stock-news.laohu8.com/highlight/detail?id=2629831820","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629831820?lang=en_us&edition=fundamental","pubTime":"2026-04-23 20:23","pubTimestamp":1776946992,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nAZN4SSCNL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629835592","title":"Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Zymeworks (ZYME) and Definium Therapeutics (DFTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629835592","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629835592?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:21","pubTimestamp":1776943291,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sanofi (SNYNF), Zymeworks (ZYME) and Definium Therap...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sanofi-othersnynf-zymeworks-zyme-and-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sanofi-othersnynf-zymeworks-zyme-and-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","LU0029874061.USD","SNYNF","BK4137","XLV","BK4585","LU0128526141.USD","HCSG","ZYME","BK4139","DFTX","BK4588","LABU","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629835596","title":"Piper Sandler Sticks to Its Buy Rating for Definium Therapeutics (DFTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629835596","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629835596?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:20","pubTimestamp":1776943241,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst David Amsellem reiterated a Buy rating on Definium Therapeutics today and set a price target of $49.00. Amsellem covers the H...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629831298","title":"U.S. RESEARCH ROUNDUP-CME Group, GE Vernova, Texas Instruments","url":"https://stock-news.laohu8.com/highlight/detail?id=2629831298","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629831298?lang=en_us&edition=fundamental","pubTime":"2026-04-23 15:46","pubTimestamp":1776930366,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-CME Group, GE Vernova, Texas InstrumentsApril 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including C","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nL4N4160NQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMZZ","CME","COF","AMZD","CCS","BIIB","AZYY","CHTR","AMZY","EFOR","COTY","BSX","T","CLX","CBRE","EWBC","ASTI","GEVX","AMZP","AVB","AKAM","CL","CYH","GEVG","TXN","CPT","MMM","CSX","ELF","BA","BWA","ELV","CRGY","CSGP","DAN","DTM","CAR","AMZU","CPAY","DLR","CALX","OZK","CHEF","LNG","ASGN","DFTX","AMZN","BKU","CPNG","ABBV","GEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629553076","title":"Definium Therapeutics: Strengthened Investment Case and Multi-Indication Upside Ahead of Key Phase 3 Readouts","url":"https://stock-news.laohu8.com/highlight/detail?id=2629553076","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629553076?lang=en_us&edition=fundamental","pubTime":"2026-04-23 05:55","pubTimestamp":1776894925,"startTime":"0","endTime":"0","summary":"Needham analyst Ami Fadia maintained a Buy rating on Definium Therapeutics today and set a price target of $28.00. Ami Fadia has given his Buy rati...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/definium-therapeutics-strengthened-investment-case-and-multi-indication-upside-ahead-of-key-phase-3-readouts-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/definium-therapeutics-strengthened-investment-case-and-multi-indication-upside-ahead-of-key-phase-3-readouts-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629207810","title":"Definium plans Phase 3 Haven trial of DT120 ODT in PTSD for 2027 start","url":"https://stock-news.laohu8.com/highlight/detail?id=2629207810","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629207810?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:36","pubTimestamp":1776890211,"startTime":"0","endTime":"0","summary":"Definium outlined near-term catalysts for DT120 ODT, with pivotal topline results scheduled for late 2Q 2026 through late 3Q 2026, meaning no new results were presented.MDD program remains central to value creation, with Emerge topline data expected late 2Q 2026.GAD readouts remain on track, with Voyage expected early 3Q 2026; Panorama timing shifted to late 3Q 2026 following a blinded reassessment of enrollment needs.Pipeline scope expanded into PTSD, with Phase 3 Haven initiation planned for 2027.Company positioned DT120 ODT as a scalable commercial franchise, targeting broad adoption across care settings ahead of potential regulatory filings.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL1JM1Tg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629078346","title":"Definium Therapeutics publishes Investor and Analyst Day presentation materials","url":"https://stock-news.laohu8.com/highlight/detail?id=2629078346","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629078346?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:27","pubTimestamp":1776889671,"startTime":"0","endTime":"0","summary":"Definium published Investor and Analyst Day presentation outlining DT120 ODT  clinical program milestones in MDD, GAD, PTSD.Emerge Phase 3 in MDD fully enrolled with 149 participants; topline data expected late 2Q 2026.PTSD expansion includes planned Phase 3 Haven study with about 200 participants; initiation expected in 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on April 22, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL9HvyzP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629702641","title":"Analysts Conflicted on These Healthcare Names: Definium Therapeutics (DFTX) and Certara (CERT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629702641","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629702641?lang=en_us&edition=fundamental","pubTime":"2026-04-23 00:40","pubTimestamp":1776876008,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Definium Therapeutics (DFTX) and Certara (CERT). Definium Therape...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-definium-therapeutics-dftx-and-certara-cert-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-definium-therapeutics-dftx-and-certara-cert-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","CERT","XLV","BK4585","HCSG","LU0128526141.USD","BK4581","DFTX","BK4137","BK4007","LU0029874061.USD","BK4588","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629047156","title":"Definium Therapeutics Is Maintained at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2629047156","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629047156?lang=en_us&edition=fundamental","pubTime":"2026-04-22 22:06","pubTimestamp":1776866760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 22, 2026 10:06 ET (14:06 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629010308","title":"Definium Therapeutics Inc : Leerink Partners Raises Target Price to $30  From $23","url":"https://stock-news.laohu8.com/highlight/detail?id=2629010308","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629010308?lang=en_us&edition=fundamental","pubTime":"2026-04-22 18:53","pubTimestamp":1776855219,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nFWN4150IN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172482246","title":"Stock Track | Definium Therapeutics Soars 6.34% in Pre-market on Trump Executive Order Boosting Psychedelic Drug Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=1172482246","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172482246?lang=en_us&edition=fundamental","pubTime":"2026-04-21 17:11","pubTimestamp":1776762674,"startTime":"0","endTime":"0","summary":"Definium Therapeutics' stock surged 6.34% in pre-market trading on Tuesday, continuing the strong momentum in psychedelic-focused biotech stocks.The rally was triggered by President Donald Trump's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629086910","title":"Definium Therapeutics (DFTX) Stock Gains After Hours: Here's What's Driving The Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2629086910","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629086910?lang=en_us&edition=fundamental","pubTime":"2026-04-21 15:44","pubTimestamp":1776757440,"startTime":"0","endTime":"0","summary":"Definium Therapeutics stock rises after hours amid psychedelic sector rally following Trump's regulatory push.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/21/Stock-Market-Analysis-Shows-Trading-Patt.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/21/Stock-Market-Analysis-Shows-Trading-Patt.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/26/04/51930842/definium-therapeutics-dftx-stock-gains-after-hours-heres-whats-driving-the-move","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/04/51930842/definium-therapeutics-dftx-stock-gains-after-hours-heres-whats-driving-the-move","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168677170","title":"Stock Track | Definium Therapeutics Soars 5.65% as Trump Executive Order Boosts Psychedelic Drug Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=1168677170","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168677170?lang=en_us&edition=fundamental","pubTime":"2026-04-21 10:07","pubTimestamp":1776737240,"startTime":"0","endTime":"0","summary":"Definium Therapeutics' stock surged 5.65% during Monday's trading session, mirroring gains across the psychedelic drug development sector following a significant regulatory announcement from the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629779874","title":"Psychedelic Stocks Surge After Trump Supports Using Drugs Like LSD for Mental Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2629779874","media":"Dow Jones","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629779874?lang=en_us&edition=fundamental","pubTime":"2026-04-21 09:54","pubTimestamp":1776736485,"startTime":"0","endTime":"0","summary":"An executive order aims to speed up how quickly psychedelic drugs for mental illness can move through the regulatory process","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Trump Supports Using Drugs Like LSD for Mental Health","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMPS","ATAI","BK4139","BK4539","GHRS","HELP","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629775545","title":"Definium Therapeutics issues inducement stock options for 70,860 shares to new hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2629775545","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629775545?lang=en_us&edition=fundamental","pubTime":"2026-04-21 04:01","pubTimestamp":1776715282,"startTime":"0","endTime":"0","summary":"Definium Therapeutics issued inducement stock options covering 70,860 common shares to five newly hired non-executive employees.Grant dates were set for April 6, 2026 and April 20, 2026.Exercise price equals closing price of Definium common shares on each grant date.Vesting runs four years with 25% on first anniversary of grant date.Remaining 75% vests in substantially equal monthly installments over next three years, subject to continued employment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on April 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL2vgXzn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}